The Anti-Parkinsonian A2A Receptor Antagonist Istradefylline (KW-6002) Attenuates Behavioral Abnormalities, Neuroinflammation, and Neurodegeneration in Cerebral Ischemia: An Adenosinergic Signaling Link Between Stroke and Parkinson's Disease.

抗帕金森病 A2A 受体拮抗剂伊斯特拉地芬林 (KW-6002) 可减轻脑缺血中的行为异常、神经炎症和神经退行性变：中风与帕金森病之间的腺苷能信号联系